Finance

Beta
Lists
ASMB:NASDAQ
Assembly Biosciences Inc
$26.74
+10.22%
(+2.48) 1D
$27.24
+1.87% (+0.50)
After hours
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ASMB...
Open
$24.26
High
$27.05
Low
$24.26
Mkt. cap
529.91M
Avg. vol.
205.15K
Volume
1.59M
52-wk high
$39.70
52-wk low
$16.81
EPS
-$1.29
Beta
1.08
Shares outstanding
19.82M
No. of employees
73
Open
$24.26
High
$27.05
Low
$24.26
Mkt. cap
529.91M
Avg. vol.
205.15K
Volume
1.59M
52-wk high
$39.70
52-wk low
$16.81
EPS
-$1.29
Beta
1.08
Shares outstanding
19.82M
No. of employees
73
News stories
From sources across the web
About Assembly Biosciences Inc
CEO-
Employees73
Founded2005
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websiteassemblybio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ASMB in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ASMB in the last 3 months.
Highest
Current $26.74
$50.00 (+86.99%)
Average
$46.00 (+72.03%)
Lowest
$43.00 (+60.81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Mizuho Securities
Buy
Maintained
$45.00
+68.3%
06/12/2026
Salim Syed
Mizuho Securities
Buy
Maintained
$45.00
+68.3%
06/12/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$50.00
+87%
06/03/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$43.00
+60.8%
05/28/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.54 / -$0.64
+15.18%beat
Revenue / Est. (USD)
8.21M / 6.95M
+18.19%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
9.63M
10.79M
42.47M
8.21M
Cost of goods sold
16.12M
16.59M
17.25M
14.90M
Cost of revenue
16.12M
16.59M
17.25M
14.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.59M
5.08M
5.42M
4.68M
Operating expense
4.59M
5.08M
5.42M
4.68M
Total operating expenses
20.72M
21.67M
22.67M
19.58M
Operating income
-11.09M
-10.88M
19.80M
-11.37M
Other non operating income
-
-
-
-
EBT including unusual items
-10.20M
-9.20M
22.09M
-9.08M
EBT excluding unusual items
-10.20M
-9.20M
22.09M
-9.08M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.20M
-9.20M
22.09M
-9.08M
Net profit margin
-105.94%
-85.23%
52.01%
-110.54%
Earnings per share
-1.33
-0.72
2.48
-0.54
Interest and investment income
895.00K
1.69M
2.29M
2.29M
Interest expense
-
-
-
-
Net interest expenses
895.00K
1.69M
2.29M
2.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.06M
-10.85M
19.83M
-11.34M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of ASMB
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer